Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Equity (Parenthetical)

v3.24.1.u1
Consolidated Statements of Equity (Parenthetical) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]    
Common shares outstanding (in shares) 112,640,861 112,513,857
Share-based compensation issued, net of redemptions (in shares) 85,509 89,964